Status:
RECRUITING
Predicting Postoperative Chemotherapy Efficacy in Patients With Esophageal Squamous Cell Carcinoma
Lead Sponsor:
City of Hope Medical Center
Conditions:
Esophageal Squamous Cell Carcinoma
Chemotherapy Effect
Eligibility:
All Genders
20+ years
Brief Summary
Esophageal cancer remains a disease with a poor prognosis. Chemotherapy is an important part of its treatment, but there are cases in which chemotherapy is ineffective. The investigators aim to develo...
Detailed Description
Esophageal cancer remains a disease with a poor prognosis. In the treatment of esophageal squamous cell carcinoma (ESCC), multidisciplinary treatment including surgery, chemotherapy, and radiation the...
Eligibility Criteria
Inclusion
- Patients who had histologically confirmed esophageal squamous cell carcinoma.
- Patients who had undergone chemotherapy.
- Patients receiving initial chemotherapy
- Written informed consent following full study information is provided to the patient.
Exclusion
- Patients for whom a preoperative biopsy sample cannot be obtained
- Patients who cannot assess at 2 months later after chemotherapy.
- Patients with multiple cancers.
Key Trial Info
Start Date :
June 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 18 2026
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT06490003
Start Date
June 1 2004
End Date
June 18 2026
Last Update
July 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yamanashi Universiy
Chūō, Yamanashi, Japan, 4093898